The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: The significance of plasma adiponectin levels

European Journal of Endocrinology

Volumn 158, Issue 2, 2008, Pages 189-195

  Imamura, Akiko ^a   Takahashi, Ryotaro ^a   Murakami, Ryuichiro ^a   Kataoka, Hiroki ^a   Cheng, Xian Wu ^b   Numaguchi, Yasushi ^c   Murohara, Toyoaki ^a   Okumura, Kenji ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Cardiovascular Research Medicine   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE SYNTHASE; APOLIPOPROTEIN A1; ASPARTIC ACID; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMINE; NOS3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; METABOLIC DISORDER; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASODILATATION; BLOOD; BLOOD FLOW; GENETICS; MALE; OXIDATIVE STRESS; PHYSIOLOGY; REFERENCE VALUE; VASCULAR ENDOTHELIUM;

ADIPONECTIN; ADULT; APOLIPOPROTEIN A-I; ASPARTIC ACID; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; GLUTAMINE; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; REFERENCE VALUES; REGIONAL BLOOD FLOW; RISK FACTORS; VASODILATION;

EID: 38949139597     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0632     Document Type: Article

References (41)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607.
2. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefl M, Shitrit A & Fuchs Z. Hyperinsulinemia. A link between hypertension, obesity, and glucose intolerance. Journal of Clinical Investigation 1985 75 809-817.
3. Matsuzawa Y, Funahashi T, Kihara S & Shimomura I. Adiponectin and metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 29-33.
4. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M & Shimomura. I. Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation 2004 114 1752-1761.
5. Hong Y, Pedersen NL, Brismar K & de Faire U. Genetic and environmental architecture of features of the insulin-resistance syndrome. American Journal of Human Genetics 1997 60 143-152.
6. Santaniemi M, Kesaniemi YA & Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. European Journal of Endocrinology 2006 155 745-750.
7. Baron AD & Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Annual Review of Nutrition 1997 17 487-499.
8. Roy D, Perreault M & Marette A. Insulin stimulation of glucose uptake in skeletal muscle and adipose tissue in vivo is NO dependent. American Journal of Physiology. Endocrinology and Metabolism 1998 274 E692-E699.
9. Phillips SA, Hatown OA & Gutterman D. The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. American Journal of Physiology, Heart and Circulatory Physiology 2007 292 H193-H100.
10. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B & Scherrer U. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001 104 342-345.
11. Cook S, Hugli O, Egli M, Menard B, Thalmann S, Sartori C, Perrin C, Nicod P, Thorens B, Volleweider P & Scherrer U, Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 2004 53 2067-2072.
12. Ohtoshi K, Yamasaki Y, Gorogawa S, Hayaishi-Okano R, Node K, Matsuhisa M, Kajimoto Y & Hori M. Association of -786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 2002 45 1594-1601.
13. Tso AWK, Tan KCB, Wat NMS, Janus ED, Lam TH & Lam KSL. Endothelial nitric oxide synthase G894T (Glu298Asp) polymorphism was predictive of glycemic status in a 5-year prostective study of Chinese subjects with impaired glucose tolerance. Metabolism 2006 55 1155-1158.
14. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzaini C, Setola E, Valsecchi G, Lucotti P, Pozza G, Bernardinelli L, Casari G & Piatti P. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003 52 1270-1275.
15. Antoniades C, Tousoulis D, Vasihadou C, Pitsavos C, Ghrysochoou C, Panagiotakos D, Tentolouris C, Marinou K, Koumallos N & Steianadis C. Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. Journal of the American College of Cardiology 2005 46 1101-1109.
16. Gonzalez-Sanchez JL, Martinez-Larrad MT, Saez ME, Zabena C, Martinez-Calatrava MJ & Serrano-Rios M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clinical Chemistry 2007 53 91-97.
17. Celermajer DS, Sorenson KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK & Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992 340 1111-1115.
18. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T & Nakano Y, Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked inummosorbent assay to detect HMW adiponectin. Diabetes 2006 55 1954-1960.
19. Okumura K, Matsui H, Kawakami K, Numaguchi Y, Hayakawa M, Morishima I, Toki Y & Ito T. Low density lipoprotein particle size is associated with glycosylated hemoglobin levels regardless of lasma lipid levels. Internal Medicine 1998 37 273-279.
20. Kotani K, Maekawa M, Kanno T, Kondo A, Toda N & Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochimica et Biophysica Acta 1994 1215 121-125.
21. Excoffier L & Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution 1995 12 921-927.
22. Awata T, Neda T, Iizuka H, Kurihara S, Ohkubo T, Takata N, Osaki M, Watanabe M, Nakashima Y, Sawa T, Inukai K, Inoue I, Shibuya M, Mori K, Yoneya S & Katayama S. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 2004 27 2184-2190.
23. Anderson TJ, Elstein E, Haber H & Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). Journal of the American College of Cardiology 2000 35 60-66.
24. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr Lerman A. Long-term follow-up of patients with mid coronary artery disease and endothelial dysfunction. Circulation 2000 101 948-954.
25. Schachinger V, Britten MB & Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000 101 1899-1906.
26. Tanus-Santos JE, Desai M & Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001 11 719-725.
27. Paradossi U, Ciofini E, Clerico, A, Botto N, Biagini A & Colombo MG. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298 ← Asp and T-786 ← C polymorphisms. Stroke 2004 35 1305-1309.
28. Rossi GP. Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, Versari D, Sudano I, Pessina AC & Salvetti A. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. Journal of the American College of Cardiology 2003 41 938-945.
29. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM & Brown MJ. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery-disease in the UK. Circulation 1999 100 1515-1520.
30. Yoshimura M, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Nakamura S, Ito T, Mizuno Y, Harada E,, Yasue H, Miyamoto Y, Saito Y & Nakao K. AT-786 ← C mutation inthe 5m-flanking region of the endothelial nitric oxide synthasc gene and coronary arterial vasomotility. American Journal of Cardiology 2000 85 710-714.
31. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP & Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. PNAS 2000 97 2832-2835.
32. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ & Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298) ← Asp variant of human endothelial nitric-oxide synthase. Journal of Biological Chemistry 2001 276 26674-26679.
33. Abe K, Nakayama M, Yoshimura M, Nakamura S, Ito T, Yamamuro M, Sakamoto T, Miyamoto Y, Yoshimasa. Y, Saito Y, Nakao K, Yasue H & Ogawa H. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism. Pharmacogenetics and Genomics 2005 15 329-336.
34. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T & Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
35. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA & Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 2004 279 12152-12162.
36. Chow WS, Cheung BM, Tso AW Xu A, Wa NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED, Lam TH & Lam KS. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year rospective study. Hypertension 2007 49 1455-1461.
37. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo, F, Vecchione C & Trimarco B. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001 32 735-740.
38. Joshi MS, Mineo C, Shaul PW & Bauer JA. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB Journal 2007 21 2655-2663.
39. Miner SE, Al-Hesayen A, Kelly S, Benson T, Thiessen JJ, Young VR & Parker JD. L-arginine transport in the human coronary and peripheral circulation. Circulation 2004 109 1278-1283.
40. Frank PG, Woodman SE, Park DS & Lisanti MP Caveolin, caveolae, and endothelial cell function. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 1161-1168.
41. Reaven GM, Chen YD, Jeppesen J, Maheux P & Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density Upoprotein particles. Journal of Clinical Investigation 1993 92 141-146.